Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Jun. 9, 8:01 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #17 of 100 |
Slide #17. Mallinckrodt Pharmaceuticals — Questcor Pharmaceuticals
Acquirer:
Mallinckrodt Pharmaceuticals (MNK)
Acquiree:
Questcor Pharmaceuticals (QCOR)
Details:
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuticals company, and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a high-growth biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion. The transaction was unanimously approved by the Boards of Directors of both companies. Subject to customary closing conditions, the transaction is currently expected to be completed in the third calendar quarter of 2014.
Mallinckrodt develops, manufactures, and markets pharmaceutical products and diagnostic imaging agents. Co. focuses on the manufacturing of pain management medications. Co provides its products to several wholesalers and retail drug store chains.
Open the MNK Page at The Online Investor »
Mallinckrodt develops, manufactures, and markets pharmaceutical products and diagnostic imaging agents. Co. focuses on the manufacturing of pain management medications. Co provides its products to several wholesalers and retail drug store chains.
Open the QCOR Page at The Online Investor »
|
|||||||||||||||
|
||||||||||||
 Free Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
